STORM Therapeutics appoints Dr. Josefin-Beate Holz as Chief Medical Officer

23 June 2020, Cambridge, UK: STORM Therapeutics, the leading biotechnology company focused on the discovery and development of small molecule therapies modulating RNA epigenetics, today announces the appointment of Dr. Josefin-Beate Holz as Clinical Advisor and Chief Medical Officer.

Dr. Holz has over 25 years’ experience in pharmaceutical drug development in Europe and North America. She has held executive managerial positions at international pharmaceutical & biotech companies Ablynx, GPC-Biotech, Gilead Sciences, Bristol-Myers Squibb and LEO Pharma. Dr. Holz has worked on more than 50 disease targets at various stages of clinical validation across oncology, immunology and other indications.

Read more

By Optimum

For more information about Optimum Strategic Communications, please get in touch

We'd love to hear from you...